As body surface area went up, the odds for nintedanib dose reduction/discontinuation went down. Researchers found lower 1-year survival rates with a body surface area of 1.73 m 2 or less vs. more ...

The impact of body mass index (BMI) and body surface area (BSA) on treatment outcome to vascular endothelial growth factor (VEGF)-targeted therapy in metastatic renal cell carcinoma: Results from a ...